Exhibit 99.1

 

 

 

HeartCore Reports Second Quarter 2026 Financial Results

 

NEW YORK and TOKYO, August 13, 2026 (GLOBE NEWSWIRE) – HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, reported financial results for the second quarter ended June 30, 2026.

 

Recent Operational Highlights

 

As of June 30, 2026, HeartCore was engaged with 16 Go IPO clients, including 6 clients currently in various stages of preparation for potential initial public offerings and U.S. exchange listings.
   
Entered into an agreement with Luvina Software Joint Stock Company to divest the Company’s 51% equity interest in HeartCore Luvina Vietnam Company Limited (“HeartCore Luvina”) as part of ongoing portfolio optimization.
   
Completed the strategic divestiture of Sigmaways, Inc. (“Sigmaways”), concentrating the Company’s business on Go IPO consulting, capital markets advisory, and financial services.
   
Regained compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).

 

Management Commentary

 

HeartCore CEO Sumitaka Kanno commented: “During the first half of 2026, we took decisive steps to simplify HeartCore’s operating structure and sharpen our strategic focus. The divestiture of Sigmaways and the pending disposition of our 51% equity interest in HeartCore Luvina Vietnam represent important components of our ongoing portfolio optimization and will allow us to further concentrate resources on our core Go IPO and planned launch of our financial services business. The Nasdaq listing environment remains selective and compliance-driven, reinforcing the importance of disciplined client selection and thorough preparation. Accordingly, we are prioritizing opportunities with clients that we believe demonstrate stronger fundamentals, organizational readiness, and a clear path toward satisfying U.S. regulatory and exchange-listing requirements. With a streamlined portfolio and a more focused pipeline, we believe HeartCore is better positioned to deepen client relationships and advance its capital markets and financial services initiatives.”

 

Second Quarter 2026 Financial Results

 

Revenues increased by 71.6% to $321,000, compared to $187,000 in the same period last year. The increase was primarily due to an increase in software development services revenue in connection with additional customer orders obtained by HeartCore Luvina, the Company’s Vietnamese subsidiary, partially offset by a decrease in Go IPO consulting services revenue primarily due to fewer Go IPO customers and extensions of IPO timelines by IPO customers during the current period.

 

Gross loss was $70,000, compared to gross loss of $23,000 in the same period last year. The increase in gross loss was primarily due to a decrease in gross profit from Go IPO consulting services, as the Company devoted additional efforts and resources, and incurred more outsourcing expenses, to enhance its Go IPO consulting customer experience, partially offset by an increase in gross profit from software development services in light of the increase in sales.

 

Operating expenses were $754,000, compared to $745,000 in the same period last year. The increase was primarily due to an increase in general and administrative expenses, partially offset by a decrease in selling expenses.

 

 

 

 

 

Net loss was $2.0 million, compared to net income of $1.1 million in the same period last year, as a result of the aforementioned increase in gross loss, a shift from other income to other expenses, and a loss from discontinued operations.

 

Adjusted EBITDA was $(1.3) million for the second quarter of 2026, compared to Adjusted EBITDA of $(0.1) million in the same period last year.

 

Six Months Ended June 30, 2026 Financial Results

 

Revenues increased by 25.9% to $554,000 for the first six months of 2026, compared to $440,000 in the same period last year. The increase was primarily due to an increase in software development services revenue in connection with additional customer orders obtained by HeartCore Luvina, partially offset by a decrease in Go IPO consulting services revenue primarily due to fewer Go IPO customers and extensions of IPO timelines by IPO customers during the current period.

 

Gross loss was $178,000, compared to gross profit of $75,000 in the same period last year. The decline in gross profit was primarily due to a decrease in gross profit from Go IPO consulting services, as the Company devoted additional efforts and resources to enhance its Go IPO consulting customer experience, resulting in a gross loss from Go IPO consulting services, partially offset by an increase in gross profit from software development services in light of the increase in sales.

 

Operating expenses were $2.0 million, compared to $1.9 million in the same period last year. The increase was primarily due to an increase in general and administrative expenses, partially offset by a decrease in selling expenses.

 

Net loss was $4.0 million, compared to a net loss of $2.1 million in the same period last year, as a result of the aforementioned decrease in gross profit, an increase in other expenses, and a loss from discontinued operations.

 

Adjusted EBITDA was $(2.9) million for the six months ended June 30, 2026, compared to Adjusted EBITDA of $(1.2) million in the same period last year.

 

As of June 30, 2026, the Company had cash and cash equivalents of $587,000.

 

 

 

 

 

 

About HeartCore Enterprises, Inc.

 

HeartCore Enterprises, Inc. is headquartered in Tokyo, Japan, and is a leading consulting services company providing U.S. market listing support and related advisory services primarily to Japanese corporate clients. For more information, please visit https://heartcore-enterprises.com/.

 

Non-GAAP Financial Measures

 

This document includes references to Adjusted EBITDA, which is a non-GAAP financial measure. For the purposes of this presentation, Adjusted EBITDA is calculated by adjusting net loss to exclude depreciation and amortization, changes in fair value of investments in marketable securities, changes in fair value of investment in warrants, changes in fair value of derivative liability, interest income, interest expenses, other income, and other expenses.

 

This measure is presented as supplemental information and is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the U.S. (“GAAP”).

 

Management believes that Adjusted EBITDA provides useful information to investors by highlighting the Company’s core operational performance, excluding non-cash and non-recurring items. However, non-GAAP financial measures have limitations and should not be considered in isolation or as a substitute for financial results prepared in accordance with GAAP.

 

    For the six months ended June 30, 
Item   2026    2025 
Net loss   ($4.0) million    ($2.1) million 
(+) Depreciation   $0.0 million    $0.0 million 
(+) Changes in fair value of investments in marketable securities   $0.8 million    $0.9 million 
(+) Changes in fair value of investment in warrants   $0.0 million    ($0.1) million 
(+) Changes in fair value of derivative liability   ($0.0) million    $0.0 million 
(+) Interest income   ($0.0) million    ($0.0) million 
(+) Interest expenses   $0.0 million    $0.0 million 
(+) Other income   ($0.0) million    ($0.0) million 
(+) Other expenses   $0.3 million    $0.0 million 
Adjusted EBITDA   ($2.9) million    ($1.2) million 

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

 

HeartCore Investor Relations Contact:

 

Gateway Group, Inc.

John Yi and Steven Shinmachi

HTCR@gateway-grp.com

(949) 574-3860

 

 

 

 

 

HEARTCORE ENTERPRISES, INC.

CONSOLIDATED BALANCE SHEETS

 

   June 30,   December 31, 
   2026   2025 
   (Unaudited)     
ASSETS          
Current assets:          
Cash and cash equivalents  $587,074   $1,904,826 
Accounts receivable   62,770    22,830 
Investments in marketable securities   2,668,317    3,690,187 
Prepaid expenses   114,340    127,565 
Deferred offering costs   250,000    250,000 
Other current assets   113,670    208,503 
Current assets of discontinued operations   -    920,683 
Proceeds receivable from sale of discontinued operations   467,970    1,291,298 
Total current assets   4,264,141    8,415,892 
           
Non-current assets:          
Property and equipment, net   252,389    275,465 
Operating lease right-of-use assets   412,976    17,781 
Long-term investment in warrants   121,774    280,924 
Deferred tax assets   22,286    23,121 
Security deposits   270,525    281,313 
Other non-current assets   816    549 
Non-current assets of discontinued operations   -    29,437 
Long-term proceeds receivable from sale of discontinued operations   3,520,918    3,736,995 
Total non-current assets   4,601,684    4,645,585 
           
Total assets  $8,865,825   $13,061,477 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable and accrued expenses  $286,711   $299,042 
Accounts payable and accrued expenses - related party   33,946    124,618 
Accrued payroll and other employee costs   88,057    64,203 
Due to related party   460    285 
Insurance premium financing   66,327    13,430 
Operating lease liabilities, current   280,326    17,781 
Income tax payables   1,737,804    1,857,386 
Deferred revenue   568,773    676,216 
Derivative liability   74,461    121,719 
Other current liabilities   523,236    526,984 
Current liabilities of discontinued operations   -    1,628,586 
Total current liabilities   3,660,101    5,330,250 
           
Non-current liabilities:          
Operating lease liabilities, non-current   139,094    - 
Non-current liabilities of discontinued operations   -    448,376 
Total non-current liabilities   139,094    448,376 
           
Total liabilities   3,799,195    5,778,626 
           
Shareholders’ equity:          
Preferred shares, $0.0001 par value, 20,000,000 shares authorized; Series A convertible preferred shares, 4,000 shares designated, 617 and 1,017 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively; aggregate liquidation preference of $748,228 and $1,158,362 as of June 30, 2026 and December 31, 2025, respectively   419,741    691,858 
Common shares, $0.0001 par value, 200,000,000 shares authorized, 1,441,565 and 1,270,991 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively*   144    127 
Additional paid-in capital   22,128,976    21,902,169 
Accumulated deficit   (17,650,321)   (13,755,534)
Accumulated other comprehensive loss   (2,702)   (58,497)
Total HeartCore Enterprises, Inc. shareholders’ equity   4,895,838    8,780,123 
Non-controlling interests   170,792    (1,497,272)
Total shareholders’ equity   5,066,630    7,282,851 
           
Total liabilities and shareholders’ equity  $8,865,825   $13,061,477 

 

 

 

 

 

 

HEARTCORE ENTERPRISES, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

 

   For the Six Months 
   Ended June 30, 
   2026   2025 
         
Revenues  $553,926   $439,909 
Cost of revenues (including cost of revenues resulting from transactions with a related party of $151,143 and $265,678 for the three and six months ended June 30, 2026, respectively, and of $31,328 and $56,523 for the three and six months ended June 30, 2025, respectively)   732,056    365,142 
Gross profit (loss)   (178,130)   74,767 
           
Operating expenses:          
Selling expenses   69,203    214,596 
General and administrative expenses (including general and administrative expenses resulting from transactions with a related party of nil for the three and six months ended June 30, 2026, and of $11,433 and $29,048 for the three and six months ended June 30, 2025, respectively)   1,888,888    1,708,906 
Total operating expenses   1,958,091    1,923,502 
           
Loss from continuing operations   (2,136,221)   (1,848,735)
           
Other income (expenses):          
Changes in fair value of investments in marketable securities   (817,491)   (928,955)
Changes in fair value of investment in warrants   (16,635)   72,660 
Changes in fair value of derivative liability   47,258    - 
Interest income   601    3,444 
Interest expenses   (4,477)   (5,874)
Other income   31,181    22,995 
Other expenses   (349,386)   (913)
Total other income (expenses)   (1,108,949)   (836,643)
           
Income (loss) from continuing operations before income tax expense   (3,245,170)   (2,685,378)
           
Income tax expense   38,341    45,581 
           
Net income (loss) from continuing operations   (3,283,511)   (2,730,959)
Income (loss) from discontinued operations, net of income tax   (732,723)   655,084 
Net income (loss)   (4,016,234)   (2,075,875)
Less: net income from continuing operations attributable to non-controlling interests   30,074    18,888 
Less: loss from discontinued operations attributable to non-controlling interests   (151,521)   (107,673)
Net income (loss) attributable to HeartCore Enterprises, Inc.   (3,894,787)   (1,987,090)
Dividends accrued on Series A convertible preferred shares   (47,324)   (611)
Net income (loss) attributable to HeartCore Enterprises, Inc. common shareholders  $(3,942,111)  $(1,987,701)
           
Other comprehensive income (loss):          
Foreign currency translation adjustment   (34,513)   48,038 
           
Total comprehensive income (loss)   (4,050,747)   (2,027,837)
Less: comprehensive loss attributable to non-controlling interests   (130,384)   (89,935)
Comprehensive income (loss) attributable to HeartCore Enterprises, Inc.  $(3,920,363)  $(1,937,902)
           
Net income (loss) from continuing operations attributable to HeartCore Enterprises, Inc. per common share*          
Basic  $(2.51)  $(2.49)
Diluted  $(2.51)  $(2.49)
           
Income (loss) from discontinued operations per common share*          
Basic  $(0.43)  $0.69 
Diluted  $(0.43)  $0.69 
           
Net income (loss) attributable to HeartCore Enterprises, Inc. per common share*          
Basic  $(2.94)  $(1.80)
Diluted  $(2.94)  $(1.80)
           
Weighted average common shares outstanding*          
Basic   1,341,297    1,103,617 
Diluted   1,341,297    1,105,245 

 

 

 

 

 

 

HEARTCORE ENTERPRISES, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   For the Six Months Ended 
   June 30, 
   2026   2025 
         
Cash flows from operating activities of continuing operations:          
Net loss  $(4,016,234)  $(2,075,875)
Income (loss) from discontinued operations, net of income tax   (732,723)   655,084 
Net loss from continuing operations   (3,283,511)   (2,730,959)
Adjustments to reconcile net loss from continuing operations to net cash flows used in operating activities of continuing operations:          
Depreciation expense   15,394    28,728 
Loss on disposal of property and equipment   -    116,981 
Non-cash lease expense   133,553    30,620 
Gain on termination of lease   -    (9,059)
Deferred income taxes   -    27,673 
Stock-based compensation   2,031    60,204 
Changes in fair value of investments in marketable securities   817,491    928,955 
Changes in fair value of investment in warrants   16,635    (72,660)
Changes in fair value of derivative liability   (47,258)   - 
Gain on settlement of asset retirement obligations   -    (45,873)
Changes in assets and liabilities:          
Accounts receivable   (40,102)   (30,439)
Prepaid expenses   120,260    60,557 
Other assets   83,271    152,927 
Accounts payable and accrued expenses   (9,464)   (106,918)
Accounts payable and accrued expenses - related party   (90,717)   (23,386)
Accrued payroll and other employee costs   25,945    (35,053)
Due to related party   191    (884)
Operating lease liabilities   (126,904)   (23,648)
Income tax payables   11,150    (105,946)
Deferred revenue   (107,443)   (190,163)
Other liabilities   (3,278)   2,865 
Net cash flows used in operating activities of continuing operations   (2,482,756)   (1,965,478)
           
Cash flows from investing activities of continuing operations:          
Purchases of property and equipment   (1,840)   - 
Proceeds from sale of marketable securities   346,894    1,071,732 
Net cash flows provided by investing activities of continuing operations   345,054    1,071,732 
           
Cash flows from financing activities of continuing operations:          
Payments for finance lease   -    (8,375)
Repayment of insurance premium financing   (55,103)   (65,257)
Proceeds from issuance of common shares related to at the market offering agreement   -    30,445 
Proceeds from collection of subscription receivable   -    103,942 
Proceeds from exercise of stock options   -    117,000 
Proceeds from issuance of Series A convertible preferred shares and common shares related to securities purchase agreement, net of share issuance costs   -    1,800,000 
Net cash flows provided by (used in) financing activities of continuing operations   (55,103)   1,977,755 
           
Cash flows from discontinued operations:          
Net cash flows used in operating activities of discontinued operations   (11,397)   (709,414)
Net cash flows provided by investing activities of discontinued operations   844,198    19,904 
Net cash flows used in financing activities of discontinued operations   (22,134)   (206,988)
Net cash flows provided by (used in) discontinued operations   810,667    (896,498)
           
Effect of exchange rate changes   (16,750)   39,022 
           
Net change in cash and cash equivalents   (1,398,888)   226,533 
Cash and cash equivalents - beginning of the period   1,985,962    2,121,089 
Cash and cash equivalents - end of the period  $587,074   $2,347,622 
           
Supplemental cash flow disclosures:          
Interest paid  $30,674   $63,320 
Income taxes paid (received), net  $(17,394)  $131,118 
           
Non-cash investing and financing transactions:          
Insurance premium financing  $108,000   $139,500 
Warrants converted to marketable securities  $142,515   $- 
Operating lease right-of-use assets obtained in exchange for operating lease liabilities  $552,577   $23,495 
Dividends accrued on Series A convertible preferred shares  $47,324   $611 
Series A convertible preferred shares converted to common shares  $272,117   $- 
Issuance of common shares related to equity purchase agreement  $-   $250,000